Tyche Wealth Partners’s SeaStar Medical ICU Stock Holding History

Tyche Wealth Partners’s Portfolio ICU Stock Details ICU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,770	Closed	-$4.25K	–	354
2025 Q4	$4.25K	Hold	1,770	–	–	﹤0.01%	336
2025 Q3	$10.1K	Sell	1,770 -2,000	-53%	-$15.4K	﹤0.01%	315
2025 Q2	$16K	Hold	3,770	–	–	﹤0.01%	303
2025 Q1	$62.6K	Buy	+3,770	New	+$70.9K	0.01%	294

Other funds holding ICU

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

Tyche Wealth Partners's ICU Position: Q1 2026 in Review

Tyche Wealth Partners sold out of SeaStar Medical (ICU) in Q1 2026, closing a stake of 1,770 shares — an estimated $4.25K sold.

Tyche Wealth Partners first reported a position in ICU in Q1 2025 and held it in 4 quarters. The position peaked at $62.6K in Q1 2025. 17 funds tracked by Wall St. Rank hold ICU as of Q1 2026.

Tyche Wealth Partners reported no remaining SeaStar Medical position as of Q1 2026 after selling out during the quarter.
Tyche Wealth Partners sold 1,770 SeaStar Medical shares in Q1 2026, an estimated $4.25K.
Tyche Wealth Partners first reported a position in SeaStar Medical in Q1 2025 and held it in 4 quarters.
Tyche Wealth Partners's SeaStar Medical position peaked at $62.6K in Q1 2025.
17 funds tracked by Wall St. Rank held SeaStar Medical as of Q1 2026.

Based on Tyche Wealth Partners's 13F filing for Q1 2026, filed 6 May 2026.